• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Human papilloma virus vaccine and VITT antibody induction.

作者信息

Kanack Adam J, Laegreid Ingvild J, Johansen Silje, Reikvam Håkon, Ahlen Maria T, Padmanabhan Anand

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

The Norwegian National Unit for Platelet Immunology, University Hospital of North Norway, Tromso, Norway.

出版信息

Am J Hematol. 2022 Oct;97(10):E363-E364. doi: 10.1002/ajh.26659. Epub 2022 Aug 3.

DOI:10.1002/ajh.26659
PMID:35834243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9463111/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a10a/9463111/d6d41c1da2c2/nihms-1823039-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a10a/9463111/d6d41c1da2c2/nihms-1823039-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a10a/9463111/d6d41c1da2c2/nihms-1823039-f0001.jpg

相似文献

1
Human papilloma virus vaccine and VITT antibody induction.人乳头瘤病毒疫苗与疫苗诱导的血小板减少伴血栓形成（VITT）抗体
Am J Hematol. 2022 Oct;97(10):E363-E364. doi: 10.1002/ajh.26659. Epub 2022 Aug 3.
2
Primary ovarian insufficiency and human papilloma virus vaccines: a review of the current evidence.原发性卵巢功能不全与人类乳头瘤病毒疫苗：当前证据的综述。
Am J Obstet Gynecol. 2020 Mar;222(3):239-244. doi: 10.1016/j.ajog.2019.08.045. Epub 2019 Aug 31.
3
Immunotherapy for the treatment of penile intraepithelial neoplasia associated with human papilloma virus type 16 using topical imiquimod and human papilloma virus vaccination.采用局部咪喹莫特和人乳头瘤病毒疫苗治疗与 16 型人乳头瘤病毒相关的阴茎上皮内瘤变的免疫疗法。
Australas J Dermatol. 2021 Nov;62(4):e589-e591. doi: 10.1111/ajd.13709. Epub 2021 Aug 31.
4
The efficacy of vaccination to prevent human papilloma viruses infection at anal and oral: a systematic review and meta-analysis.疫苗接种预防肛门和口腔人乳头瘤病毒感染的效果：系统评价和荟萃分析。
Public Health. 2021 Jul;196:165-171. doi: 10.1016/j.puhe.2021.05.012. Epub 2021 Jul 3.
5
Why are U.S. girls getting meningococcal but not human papilloma virus vaccines? Comparison of factors associated with human papilloma virus and meningococcal vaccination among adolescent girls 2008 to 2012.为什么美国女孩接种脑膜炎球菌疫苗而不接种人乳头瘤病毒疫苗？2008 年至 2012 年期间，青少年女孩接种人乳头瘤病毒疫苗和脑膜炎球菌疫苗相关因素的比较。
Womens Health Issues. 2015 Mar-Apr;25(2):97-104. doi: 10.1016/j.whi.2014.12.005.
6
A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12-15 year old girls.一项比较佳达修（Gardasil(®)）和卉妍康（Cervarix(®)）人乳头瘤病毒疫苗在 12-15 岁少女中免疫原性的随机、观察者设盲临床试验
PLoS One. 2013 May 1;8(5):e61825. doi: 10.1371/journal.pone.0061825. Print 2013.
7
Rate and predictors of human papillomavirus vaccine uptake among women who have sex with women in the United States, the National Health and Nutrition Examination Survey, 2009-2012.
J Clin Nurs. 2016 Dec;25(23-24):3619-3627. doi: 10.1111/jocn.13491.
8
Human Papillomavirus neutralizing and cross-reactive antibodies induced in HIV-positive subjects after vaccination with quadrivalent and bivalent HPV vaccines.在接种四价和二价人乳头瘤病毒（HPV）疫苗后，HIV阳性受试者体内诱导产生的人乳头瘤病毒中和抗体及交叉反应抗体。
Vaccine. 2016 Mar 18;34(13):1559-1565. doi: 10.1016/j.vaccine.2016.02.019. Epub 2016 Feb 16.
9
Predictors associated with the willingness to take human papilloma virus vaccination.与接种人乳头瘤病毒疫苗意愿相关的预测因素。
J Community Health. 2012 Apr;37(2):288-93. doi: 10.1007/s10900-011-9473-4.
10
[Research status of human papillomavirus vaccine for prevention and treatment of respiratory papillomatosis].[人乳头瘤病毒疫苗预防和治疗呼吸道乳头状瘤病的研究现状]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Feb 5;33(2):189-192. doi: 10.13201/j.issn.1001-1781.2019.02.025.

引用本文的文献

1
VITT Pathophysiology: An Update.疫苗诱导的血栓性血小板减少症（VITT）的病理生理学：最新进展
Vaccines (Basel). 2025 Jun 17;13(6):650. doi: 10.3390/vaccines13060650.
2
Anti-Platelet factor 4 immunothrombosis-not just heparin and vaccine triggers.抗血小板因子4免疫性血栓形成——不仅仅是肝素和疫苗引发的。
Res Pract Thromb Haemost. 2025 Mar 12;9(2):102729. doi: 10.1016/j.rpth.2025.102729. eCollection 2025 Feb.
3
Demystifying autoimmune HIT: what it is, when to test, and how to treat.揭开自身免疫性血小板减少性紫癜的神秘面纱：它是什么、何时进行检测以及如何治疗。

本文引用的文献

1
Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT.单克隆和寡克隆抗血小板因子 4 抗体介导 VITT。
Blood. 2022 Jul 7;140(1):73-77. doi: 10.1182/blood.2021014588.
2
COVID-19 mRNA-1273 vaccine induces production of vaccine-induced immune thrombotic thrombocytopenia antibodies.新型冠状病毒肺炎mRNA-1273疫苗诱导产生疫苗诱导的免疫性血栓性血小板减少症抗体。
Am J Hematol. 2022 Jun 1;97(6):E223-E225. doi: 10.1002/ajh.26542. Epub 2022 Mar 26.
3
Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):403-408. doi: 10.1182/hematology.2024000565.
4
Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)-Insights from Clinical Cases, In Vitro Studies and Murine Models.疫苗诱导的免疫性血小板减少症和血栓形成（VITT）——来自临床病例、体外研究和小鼠模型的见解
J Clin Med. 2023 Sep 22;12(19):6126. doi: 10.3390/jcm12196126.
5
Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?疫苗诱导的免疫性血栓性血小板减少症：我们目前了解多少？
Front Med (Lausanne). 2023 May 16;10:1155727. doi: 10.3389/fmed.2023.1155727. eCollection 2023.
6
Vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症。
Blood. 2023 Apr 6;141(14):1659-1665. doi: 10.1182/blood.2022017696.
7
Vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101381. doi: 10.1016/j.beha.2022.101381. Epub 2022 Sep 13.
Ad26.COV2.S 相关疫苗诱导的免疫性血栓性血小板减少症（VITT）的持续存在和 VITT 抗体的特异性检测。
Am J Hematol. 2022 May;97(5):519-526. doi: 10.1002/ajh.26488. Epub 2022 Feb 21.
4
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.2020 年 12 月至 2021 年 8 月美国 COVID-19 疫苗接种后血栓性血小板减少综合征病例系列报告。
Ann Intern Med. 2022 Apr;175(4):513-522. doi: 10.7326/M21-4502. Epub 2022 Jan 18.
5
Thrombosis and thrombocytopenia after HPV vaccination.HPV 疫苗接种后血栓形成和血小板减少症。
J Thromb Haemost. 2022 Mar;20(3):700-704. doi: 10.1111/jth.15604. Epub 2021 Dec 7.
6
Decline in Pathogenic Antibodies over Time in VITT.疫苗诱导的血栓性血小板减少症（VITT）中致病性抗体随时间的下降
N Engl J Med. 2021 Nov 4;385(19):1815-1816. doi: 10.1056/NEJMc2112760. Epub 2021 Sep 8.
7
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.病毒样颗粒：制备、免疫原性及其作为纳米疫苗和药物纳米载体的作用。
J Nanobiotechnology. 2021 Feb 25;19(1):59. doi: 10.1186/s12951-021-00806-7.
8
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty.全膝关节置换术后并发自发性肝素诱导的血小板减少症综合征相关脑静脉窦血栓形成。
Platelets. 2021 Oct 3;32(7):936-940. doi: 10.1080/09537104.2020.1828574. Epub 2020 Oct 1.
9
A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.一项针对 HIT 诊断的 PF4 依赖性检测的前瞻性、盲法研究。
Blood. 2021 Feb 25;137(8):1082-1089. doi: 10.1182/blood.2020008195.
10
High-dose intravenous immunoglobulin to treat spontaneous heparin-induced thrombocytopenia syndrome.大剂量静脉注射免疫球蛋白治疗自发性肝素诱导的血小板减少症综合征。
J Thromb Haemost. 2019 May;17(5):841-844. doi: 10.1111/jth.14411. Epub 2019 Mar 14.